Contact information
Research groups
Anthony Cornu
Research Technician in Human Islet Isolation
I am a Research Technician at The DRWF Human Islet Isolation Facility based on the Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM) at Churchill Hospital. My work focuses on human islet isolation to support both research and clinical programs. This involves isolating, preparing, and distributing human islet cells for diabetes-related studies, as well as contributing to innovative approaches in islet transplantation.
As part of my role, I am involved in all aspects of the islet isolation process, including quality testing, maintaining laboratory protocols, and managing the distribution of islets to research centers across the UK. I will also contribute to research on improving islet isolation techniques and exploring potential pre-conditioning methods for transplantation. This work is essential for advancing our understanding of diabetes and enhancing treatment options for patients.
I have a strong background in molecular and cellular biology, with prior experience in laboratory setup and management, histology, and advanced techniques such as CRISPR/Cas9 genome editing and spectral flow cytometry. I have extensive experience in human tissue sample handling and multidisciplinary collaborations.
I am passionate about research that drives real-world impact, and I enjoy working in an environment that values precision, teamwork, and innovation. Please feel free to contact me at anthony.cornu@nds.ox.ac.uk or visit our lab at OCDEM, Churchill Hospital.
Recent publications
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.
Journal article
Falquet M. et al, (2026), Nat Commun
Neural anticipation of virtual infection triggers an immune response.
Journal article
Trabanelli S. et al, (2025), Nat Neurosci, 28, 1968 - 1977
c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells.
Journal article
Benkhoucha M. et al, (2021), Cell Mol Immunol, 18, 2051 - 2053
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.
Journal article
Ercolano G. et al, (2021), Nat Commun, 12
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer.
Journal article
Cachot A. et al, (2021), Sci Adv, 7